All News
Rheumatoid arthritis and lung disease in the spotlight at #ACR20
Rheumatoid arthritis (RA) has long been established to have pulmonary manifestations such as interstitial lung disease (ILD), and several research groups are pursuing this respiratory burden of RA at #ACR20.
Read ArticleACR20 - Day 4 Report
Here are my highlights from day four, Monday, of the ACR 2020 Convergence.
Vaccine Immunogenicity with Tofacitinib
Read Article
Significance of ANA+ in Managing RA with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/LdRaPNyJgq https://t.co/yuPq49hoLq
Links:
Dr. John Cush RheumNow ( View Tweet)
Have five minutes to spare? Check out this video titled, "HCQ and QTc in RA and SLE Patient" with Dr. Kathryn Dao ( @KDAO2011). #ACR20
https://t.co/EY6LPX25Bn https://t.co/wRM61hMelo
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RichardPAConway Dr Lillegraven presents a randomized open-label phase 4, non-Inferiority trial of TNFi tapering in RA patients in sustained remission. 63% of tapered patients flared over 12 months vs 5% of maintained. https://t.co/JwR86kJf56 https://t.co/fFRVf6TYf9
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out this quick video on lifestyle, clinical risk factors for RA-ILD with Dr. Sheila Reyes (@RHEUMarampa) #ACR20
https://t.co/7LQ7RCtiuj https://t.co/CjjtUauy2u
Links:
Dr. John Cush RheumNow ( View Tweet)
XRay Bone Erosions in CCP+ Patients with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/f6RnoExBgk https://t.co/MJCp3sR1UZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out this video on combo therapy v monotherapy (SEAM-RA Trial) with Dr. Richard Conway (@RichardPAConway). #ACR20
https://t.co/iNsmKHSnMq https://t.co/tELmueVEK0
Links:
Dr. John Cush RheumNow ( View Tweet)
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at #ACR20 annual meeting, reviewing two previous clinical trials that also looked at this question.
https://t.co/58raeaE8Mr https://t.co/ZP2P0IZ1Fc
Links:
Dr. John Cush RheumNow ( View Tweet)
View one of our fantastic #ACR20 video titled "Staying on Therapy in RA" with Dr. Janet Pope ( @Janetbirdope)
https://t.co/imCpxVs2N8 https://t.co/AcTBGaapig
Links:
Dr. John Cush RheumNow ( View Tweet)
What is the SEAMless transition from combination Etanercept to Methotrexate? with Dr. Jonathan Kay #ACR20
https://t.co/58raeaE8Mr https://t.co/FUIidcoy4I
Links:
Dr. John Cush RheumNow ( View Tweet)
Improving Drug Adherence in RA: Dr Janet Pope ( @Janetbirdope) Reviews abstract #799 presented at #ACR20.
https://t.co/ONCJmCOdzC https://t.co/ornpQiopTS
Links:
Dr. John Cush RheumNow ( View Tweet)
SEAM-RA Trial: Dr. Jeff Curtis ( @RADoctor) discusses abstract # 0939 that looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at #ACR20
https://t.co/2yMyj4BKs1 https://t.co/2gqJM4EKpG
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisiting Day 1 of #ACR20. Watch our video on what to do with subclinical synovitis. https://t.co/ynSRjiAFPe https://t.co/XeeGohW8t5
Links:
Dr. John Cush RheumNow ( View Tweet)
How are RA patients doing using telemedicine/virtual care? Dr. Janet Pope ( @Janetbirdope) weighs in. #ACR20
https://t.co/YffT28OwgY https://t.co/OvpBDwkyEp
Links:
Dr. John Cush RheumNow ( View Tweet)
An International Panel Weighs in on RA Studies from Day 1 at #ACR20
https://t.co/T8mhuRYVbf https://t.co/pMPV4bxYGK
Links:
Dr. John Cush RheumNow ( View Tweet)
"Rheumatoid arthritis and lung disease in the spotlight at #ACR20" by Dr. Jeffrey Sparks ( @jeffsparks)
https://t.co/0Dth0ko5TO https://t.co/e6HQOkXuY7
Links:
Dr. John Cush RheumNow ( View Tweet)
Racial Disparities - Stroke, Heart Attacks Risks Higher in SLE: Dr. Kathryn Dao ( @KDAO2011) discusses abstract #0433 presented Friday at #ACR20 annual meeting.
https://t.co/Jx8hiPcNKA https://t.co/MvUj41KiuQ
Links:
Dr. John Cush RheumNow ( View Tweet)
Read our news article "Ten-Year Analysis of Low-Dose Glucocorticoids in early RA" by Meral K. El Ramahi ( @MeralElRamahiMD) #ACR20.
https://t.co/S9rOHc0864 https://t.co/6X4owP6pF0
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our article titled: Outcomes Switching to Monotherapy: SEAM-RA Trial by Dr. Eric Dein ( @ejdein1). #ACR20
https://t.co/0SKSzyH1yl https://t.co/6oqb1FfSX0
Links:
Dr. John Cush RheumNow ( View Tweet)


